Mapping SOC Requirements against HIPAA, CMMC, and ISO 27001

The compliance gaps that surface during diligence are rarely new; they were always there. The difference between a clean deal and a messy one is usually whether the portfolio company was managing those gaps proactively or discovering them under buyer scrutiny. Depending on the industries they serve, the data they handle, and the contracts they hold, they may be managing SOC alongside HIPAA, CMMC, ISO 27001, or other regulatory requirements simultaneously. For private equity firms, the risk isn't just operational. When compliance frameworks are managed in silos, the gaps between them become visible during due diligence, refinancing, and exit processes at exactly the moment when they're most costly to address.

Buyers and their advisors don't evaluate compliance programs in isolation. When a portfolio company has a SOC 2 report that doesn't align with its HIPAA program, or a CMMC assessment that contradicts the control environment described in its SOC documentation, those inconsistencies raise questions about management credibility and operational discipline. They slow diligence, create negotiating leverage for buyers, and sometimes surface as deal conditions or price adjustments. The firms that manage this well treat compliance framework alignment as an investment decision. A portfolio company that can demonstrate a coherent, well-documented compliance posture across multiple frameworks is a more attractive asset than one where each program was built independently without regard for the others.

Healthcare services and health technology portfolio companies frequently carry both SOC 2 reports and HIPAA compliance programs. When these programs are managed independently, the same controls are often documented differently across each, creating inconsistencies that surface during buyer diligence. A buyer whose advisors find conflicting documentation between SOC 2 and HIPAA programs will ask tough questions about which version of the control environment is accurate. Aligning SOC 2 testing with HIPAA evidence requirements eliminates that inconsistency and reduces the total compliance burden on portfolio company management teams.

Defense industrial base portfolio companies working toward CMMC certification face a significant overlap with SOC 2 controls, particularly around access management, incident response, and system monitoring. A well-scoped SOC 2 examination can provide meaningful evidence towards CMMC requirements and reduce the total effort required for formal assessment. The stakes here go beyond diligence. CMMC is now enforcement-active, and portfolio companies that can't demonstrate meaningful progress risk losing existing government contracts, not at exit, but now. For PE firms with DIB exposure in the portfolio, that's a direct hit to revenue and enterprise value that can't be papered over in a deal process. Buyers will identify the gap, but the damage happens long before a buyer is in the room.

ISO 27001 and SOC 2 share meaningful common ground around risk management, access controls, and information security governance. Portfolio companies pursuing ISO certification alongside a SOC 2 program often duplicate evidence collection and create parallel documentation that tells slightly different stories about the same control environment. Structuring control documentation to satisfy both sets of requirements from a single evidence base eliminates that inconsistency and strengthens the overall compliance narrative during diligence.

For portfolio companies managing multiple compliance obligations, the first step is a structured review of how current programs interact. This review identifies where frameworks share control requirements, where documentation is inconsistent across programs, and where gaps in one framework create exposure in another. Conducted before the next examination period begins, it allows firms to redesign scopes and evidence collection in a way that serves multiple programs without duplicating effort.

When SOC examination periods are aligned with the timelines of other active compliance assessments, portfolio company management teams aren't repeatedly pulled into separate evidence collection processes. This is particularly important for companies with lean compliance functions where audit fatigue is a real operational risk and a potential red flag for buyers evaluating management bandwidth.

Firms that establish a consistent underlying control framework, such as NIST or ISO 27001, across portfolio companies create a foundation that multiple compliance programs can map onto. This makes it easier to demonstrate a coherent compliance posture across frameworks during diligence and reduces the portfolio-level complexity of managing companies that each took a different approach.

Fragmented compliance programs cost more to maintain and create more diligence risk than coordinated ones. Clark Schaefer Consulting helps private equity firms identify where SOC, HIPAA, CMMC, and other frameworks overlap across portfolio companies and redesign examination programs to reduce redundant effort, eliminate documentation inconsistencies, and build a compliance posture that holds up under sophisticated buyer scrutiny. Contact us to discuss what a coordinated compliance approach could look like for your portfolio.